Rang	Name	Position
1	Mr. Gary R. Maharaj	CEO, President & Director
2	Mr. Timothy J. Arens	Senior VP of Finance & Information Technology and CFO
3	Mr. Gordon S. Weber J.D.	Senior VP of Legal, General Counsel & Secretary
4	Mr. Charles W. Olson	Senior VP & President of Medical Device Coatings
5	Ms. Teryl L. W. Sides	Senior VP & President of Vascular Interventions
6	Mr. John D. Manders	Corporate Controller, VP of Finance & Principal Accounting Officer
7	Joel Suiter	Director of Corporate Development
8	Mr. Joseph J. Stich	Senior VP of Human Resources & President of In Vitro Diagnostics

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,02%	49,32 Mio. USD
2	AllianceBernstein L.P.	5,95%	36,56 Mio. USD
3	Vanguard Group Inc	5,67%	34,83 Mio. USD
4	Soleus Capital Management, L.P.	5,52%	33,92 Mio. USD
5	Morgan Stanley - Brokerage Accounts	4,59%	28,19 Mio. USD
6	Readystate Asset Management LP	3,03%	18,64 Mio. USD
7	UBS Group AG	2,96%	18,17 Mio. USD
8	Gabelli Funds LLC	2,90%	17,83 Mio. USD
9	Hudson Bay Capital Management LP	2,80%	17,19 Mio. USD
10	Qube Research & Technologies	2,76%	16,94 Mio. USD
11	Dimensional Fund Advisors, Inc.	2,48%	15,23 Mio. USD
12	Geode Capital Management, LLC	2,35%	14,45 Mio. USD
13	State Street Corp	2,24%	13,79 Mio. USD
14	Balyasny Asset Management LLC	1,90%	11,68 Mio. USD
15	ODDO BHF Asset Management SAS	1,88%	11,52 Mio. USD
16	HSBC Holdings PLC	1,87%	11,47 Mio. USD
17	Goldman Sachs Group Inc	1,61%	9,88 Mio. USD
18	Gabelli Securities Inc	1,42%	8,75 Mio. USD
19	Cnh Partners, LLC	1,09%	6,71 Mio. USD
20	Millennium Management LLC	1,09%	6,69 Mio. USD